Stock Events

Stock Events

Lipella Pharmaceuticals 

$0.032700
16
-$0.03-49.69% Friday 19:54

Statistics

Day High
0.058
Day Low
0.0327
52W High
0.8
52W Low
0.02
Volume
160,086
Avg. Volume
36,175
Mkt Cap
151,106.7
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2SepExpected
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-10.33
-7.7
-5.06
-2.43
Expected EPS
N/A
Actual EPS
N/A

Financials

-935.82%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
536,000Revenue
-5.02MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LIPO. It's not an investment recommendation.
Amazon
4
AMZN
Tesla
3
TSLA
Alphabet
3
GOOGL
AMD
3
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap123.19B
Vertex Pharmaceuticals focuses on developing treatments for cystic fibrosis and other diseases, potentially overlapping with Lipella's focus on bladder diseases and related conditions.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences is involved in the development of drugs for infectious diseases, liver diseases, and other conditions, which could compete with Lipella's therapeutic areas.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie operates in various therapeutic areas, including immunology and oncology, which might intersect with Lipella's research and development focus.
AMGEN
AMGN
Mkt Cap196.12B
Amgen focuses on human therapeutics in areas such as nephrology and inflammation, potentially competing with Lipella's products in development.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol Myers Squibb works on a broad range of disease areas, including cancer and cardiovascular diseases, which could compete with Lipella's pipeline.
Pfizer
PFE
Mkt Cap137.76B
Pfizer develops and manufactures drugs and vaccines for a wide range of medical disciplines, potentially competing across several areas with Lipella.
Merck
MRK
Mkt Cap305.12B
Merck & Co. focuses on pharmaceuticals across various areas, including cancer and infectious diseases, potentially overlapping with Lipella's focus areas.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its pharmaceutical segment, develops treatments for a broad range of health conditions, potentially competing with Lipella.
Regeneron Pharmaceuticals
REGN
Mkt Cap69.67B
Regeneron Pharmaceuticals specializes in developing medications for eye diseases, allergic and inflammatory diseases, which might compete with Lipella's therapeutic areas.
Novartis
NVS
Mkt Cap293.94B
Novartis focuses on a wide range of healthcare areas, including generics and biosimilars, potentially competing with Lipella's product development and market.

About

Lipella Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm specializing in the creation of novel therapies. The company achieves this by repurposing and optimizing the active ingredients found in established generic drugs, tailoring these reformulations for diverse medical applications. Its lead candidate, LP-10, a tacrolimus formulation, is presently in Phase IIa clinical studies, targeting radiation-induced hemorrhagic cystitis. Additionally, LP-310, another tacrolimus-derived compound, is under development for the management of oral lichen planus. Founded in 2005, the company maintains its headquarters in Pittsburgh, Pennsylvania.
Show more...
CEO
Dr. Jonathan Kaufman M.B.A., Ph.D.
Employees
7
Country
United States
ISIN
US53630L2097

Listings

OTC Link
US
LIPO

0 Comments

Share your thoughts

FAQ

What is Lipella Pharmaceuticals stock price today?▼
The current price of LIPO is $0.03 USD — it has decreased by -49.69% in the past 24 hours. Watch Lipella Pharmaceuticals stock price performance more closely on the chart.
What is Lipella Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Lipella Pharmaceuticals stocks are traded under the ticker LIPO.
Is Lipella Pharmaceuticals stock price growing?▼
LIPO stock has fallen by -49.69% compared to the previous week, the month change is a -59.12% fall, over the last year Lipella Pharmaceuticals has showed a -95.64% decrease.
What is Lipella Pharmaceuticals market cap?▼
Today Lipella Pharmaceuticals has the market capitalization of 151,106.7
When is the next Lipella Pharmaceuticals earnings date?▼
Lipella Pharmaceuticals is going to release the next earnings report on September 02, 2026.
What is Lipella Pharmaceuticals revenue for the last year?▼
Lipella Pharmaceuticals revenue for the last year amounts to 536,000 USD.
What is Lipella Pharmaceuticals net income for the last year?▼
LIPO net income for the last year is -5.02M USD.
How many employees does Lipella Pharmaceuticals have?▼
As of July 18, 2026, the company has 7 employees.
In which sector is Lipella Pharmaceuticals located?▼
Lipella Pharmaceuticals operates in the Health & Wellness sector.
When did Lipella Pharmaceuticals complete a stock split?▼
The last stock split for Lipella Pharmaceuticals was on November 08, 2024 with a ratio of 1:8.
Where is Lipella Pharmaceuticals headquartered?▼
Lipella Pharmaceuticals is headquartered in Pittsburgh, United States.